SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The upcoming Phase 3 REGAL trial readout for SELLASs AML treatment GPS dominates discussion, with traders focused on the binary clinical catalyst. Bulls anticipate strong results, while skeptics cite the stocks sharp volatility and warn of failure risk or a sell-the-news reaction; claims of short-term manipulation remain speculation.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summits FDA review of ivonescimab for EGFR-mutated lung cancer is driving a binary-outcome debate over approval versus a possible rejection or request for more evidence. Bulls point to strong progression-free-survival results and encouraging survival trends, while bears focus on the FDAs stated need for statistically significant overall-survival evidence; recent weakness has also prompted speculation about a negative outcome, though traders say price action alone is not proof.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQs sharp after-hours drop drew attention as traders linked the move to the FAAs nationwide ground stop after communications problems, while speculation about a cyberattack or AI involvement remained unverified. The discussion also reflected wider pressure on tech and AI stocks tied to uncertainty around Nvidia, with traders divided between seeing the selloff as an overreaction and expecting further weakness.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivians volatile, weak share performance is driving debate, with traders blaming heavy short-selling and persistent selling pressure while bulls point to improving deliveries, the R2 ramp, and upcoming autonomy developments. Sentiment remains split between concern over cash burn and execution and hopes that the companys growth initiatives can improve its outlook.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Reported takeover discussions involving Silver Lake and Saudi Arabias PIF are driving speculation, though no deal is confirmed; traders disagree over whether a potential offer would undervalue Unity. The interest is reinforced by strong quarterly results and the companys first GAAP-profitable quarter, with bullish call activity and breakout chatter alongside skepticism about the rally.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius selloff is being tied to its earnings outlook and delays in activating third-party data-center capacity, which push expected revenue into a later period and have prompted analyst price-target cuts. Traders are divided between viewing the execution and heavy-capex concerns as a reason for further downside and treating the drop as an overreaction, with broader weakness in AI and neocloud stocks adding pressure.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

Reports of an FAA nationwide ground stop tied to air-traffic-control communications problems are drawing attention to AAL, with traders discussing possible departure delays and rerouting. Some characterize the disruption as brief, while speculation about its cause remains unverified.

HawKeye 360, Inc. engages in the provision of defense technology. It offers spectrum monitoring, maritime intelligence, air defence radar monitoring, GNSS interference detection, and communications mapping. Its costumers include a wide range of commercial, government and international entities. The company was founded by Charles T. Clancy, Robert G. McGwier, Chris DeMay and John Serafini in 2015 and is headquartered in Herndon, VA.

HawkEye 360 Inc.

HAWK is drawing attention after reporting record third-quarter revenue and raising its full-year outlook, with traders also highlighting international growth, contract demand, and plans for lower-cost satellites. The community reaction is broadly bullish on the results and rally, though claims of institutional accumulation and further upside remain speculative.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure is driving debate over Nvidias leadership transition, with traders speculating about his return and possible successors while others worry about leadership uncertainty and scrutiny of chip exports to China. Bulls argue Nvidias business remains strong and point to earnings, while bears see unresolved risks weighing on confidence.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novos stronger-than-expected quarterly results and raised full-year outlook, driven largely by demand for its Wegovy pill, have fueled renewed buying interest. Traders are debating whether the oral drugs momentum can support a sustained recovery amid Lilly competition and concerns about Novos execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Did AAPL, COST, JNJ Stocks Hit 52-Week Highs Today?

Positive Phase 3 results for J&Js Caplyta in bipolar mania, along with anticipation of blood-cancer pipeline updates, are fueling discussion as shares reach a new 52-week high. Traders also cite defensive-sector strength, while some are taking profits after the run-up.

Why Did AAPL, COST, JNJ Stocks Hit 52-Week Highs Today? 

Equity

Investors rotated toward defensive stocks amid AI-sector uncertainty. 


See Which Recent 13F Filers Hold JNJ But Chatterton & Associates Exited

At Holdings Channel, we have reviewed the latest batch of the 91 most recent 13F filings for the 09/30/2026 reporting period, and noticed that Johnson & Johnson (Symbol: JNJ) was held by 57 of these funds. When hedge fund managers appear to be thinking alike, we find it is a...

How Did AbbVie's Immunology Franchise Fare in Q3?

ABBV's immunology sales rose 16.6% in Q3, driven by Skyrizi and Rinvoq growth, prompting higher 2026 sales forecasts despite Humira's decline.

Johnson & Johnson (JNJ) Up 10.4% Since Last Earnings Report: Can It Continue?

Johnson & Johnson (JNJ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Johnson & Johnson vs. Eli Lilly: Which Healthcare Giant's Stock Is a Better Buy for 2027?

Key PointsJohnson & Johnson maintains a massive healthcare presence across both innovative medicines and advanced medical technologies...

Johnson & Johnson Reports Favorable Data For Bipolar Study

Johnson & Johnson reports positive Phase 3 CAPLYTA study data, delivering rapid manic symptom relief for adults with bipolar I disorder.read more...

Will HALO's Partner Royalties Drive Growth for the Rest of 2026?

Halozyme's royalty revenues surged 45.8% in the first nine months of 2026, prompting higher guidance.

ABBV Stock Rises More Than 4% in a Month: Time to Buy, Hold or Sell?

AbbVie's strong immunology and neuroscience growth offset Humira erosion and persistent aesthetics and oncology challenges.

Bayer Wins FDA Approval for Sunharbo for Secondary Stroke Risk Reduction

Bayer gains FDA approval for Sunharbo, the first Factor XIa inhibitor approved worldwide, opening new growth opportunities in stroke prevention.

J&J's Oncology Sales Surge So Far in 2026: What Lies Ahead?

J&J's oncology sales surge 16.8% to $22 billion in the first nine months of 2026, fueled by blockbuster drugs and new launches.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Bearish Sentiment

<ul class="summary-bullets"><li>Apple hit a record $359.37, widening its market cap lead over Nvidia to $1.2 trillion.&nbsp;</li><li>Costco gained on momentum from its $30-per-share special dividend announcement.</li><li>Johnson &amp; Johnson rallied on positive Caplyta trial results and upcoming blood cancer pipeline updates.&nbsp;&nbsp;</li></ul>Apple Inc. (AAPL), Costco Wholesale Corp. (COST) and Johnson &amp; Johnson (JNJ) stocks climbed to fresh 52-week highs on Thursday as investors moved away from volatile AI stocks and into established companies with strong cash flows&nbsp;and promising clinical developments.&nbsp;Johnson &amp; Johnson and Costco stocks gained 1% and 0.4%, respectively, while Apple pared its gains and ended the session 0.2% lower.&nbsp;<h2 class="st-heading-2">Apple Gains Ground As Investors Seek Stability</h2><a href="https://stocktwits.com/symbol/AAPL">Apple stock</a> surged to an all-time high of $359.37 as the company strengthened its position among the world's largest publicly traded companies, expanding its market capitalization advantage over Nvidia to approximately $1.2 trillion.&nbsp;According to CNBC, Bernstein analysts pointed to similarities between Apple's investment profile and traditional retailers such as Costco and Walmart, highlighting its customer loyalty, recurring cash generation and dependable earnings.Apple also drew attention after speculation that former CEO Tim Cook could lead Nvidia, after President Donald Trump publicly&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/117604177898784579">suggested</a> Cook could replace Jensen Huang, calling it a legendary leader succeeding another.&nbsp;On Stocktwits, retail sentiment around the stock changed to ‘neutral’ from ‘bullish’.&nbsp;<h2 class="st-heading-2">Costco's $13.3 Billion Shareholder Payout Draws Interest</h2><a href="https://stocktwits.com/symbol/COST">Costco Wholesale stock</a> also hit a record high of $1,102.84 as it attracted investors’ interest after approving a special cash distribution of $30 per share on Tuesday, its largest one-time dividend to date. The payment represents an estimated $13.3 billion distribution to shareholders, with Dec. 4 set as the payment date.&nbsp;Mizuho said the distribution exceeded its earlier expectations of $18 to $20 per share. The retailer also approved a separate $4 billion stock repurchase authorization extending through November 2030, replacing its previous buyback arrangement.Retail sentiment around the stock remained ‘bullish’.&nbsp;<h2 class="st-heading-2">Johnson &amp; Johnson Advances On Clinical Progress</h2><a href="https://stocktwits.com/symbol/JNJ">Johnson &amp; Johnson stock</a> also reached a fresh all-time high of $286.08 as investors responded to positive developments in its pharmaceutical business. The healthcare company reported encouraging results from a second pivotal Phase 3 study evaluating Caplyta (lumateperone) for bipolar mania.&nbsp;Investors are also watching the upcoming American Society of Hematology 2026 meeting, where Johnson &amp; Johnson plans to present additional research involving its blood cancer treatments. The company's neuroscience and oncology pipeline provides further potential catalysts.Retail sentiment around the stock remained ‘bearish’.&nbsp;Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-mod-stock-soaring-28-overnight-today/cNbbZmRR9OB">Why Is MOD Stock Soaring 28% Overnight Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Consumers shop in an APPLE smart home store in Shanghai, China, on May 13, 2025. (Photo by Costfoto/NurPhoto via Getty Images)

Apple Inc. (AAPL), Costco Wholesale Corp. (COST) and Johnson & Johnson (JNJ) stocks climbed to fresh 52-week highs on Thursday as investors moved away from volatile AI stocks and into established companies with strong cash flows and promising clinical dev

Apple Inc

Costco Wholesale Corp

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$2.91	--	--	N/A
Q3 '26	$2.52	$2.59	2.68%	BEAT
Q2 '26	$2.85	$2.90	1.59%	BEAT
Q1 '26	$2.68	$2.70	0.85%	BEAT
Q4 '25	$2.46	$2.46	-0.12%	MISSED

Feed

News

Sentiment

Earnings

Futures

Fundamentals

Info

JNJ Earnings

Upcoming Earnings: Q4 '26

Historical Earnings